NCT03669939

Brief Summary

The overarching plan for TOWER is to develop and test an algorithmic version of the Center for Disease Control Guidelines (CDCG) tailored for a specific primary care setting, the HIV primary care clinic. This CDCG intervention incorporates communication and implementation strategies tailored for the HIV primary care setting, and enabled with technology (an app for use by patients and EMR tools for providers).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

September 13, 2018

Completed
22 days until next milestone

Study Start

First participant enrolled

October 5, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
Last Updated

October 9, 2020

Status Verified

October 1, 2020

Enrollment Period

2 years

First QC Date

August 22, 2018

Last Update Submit

October 8, 2020

Conditions

Keywords

Center for Disease Control GuidelinesOpioids for chronic paincommunication strategies

Outcome Measures

Primary Outcomes (1)

  • Proportion of eligible PCPs who successfully complete randomization

    Feasibility of recruitment and randomization of PCPs, reflected by the proportion of eligible PCPs who successfully complete randomization (where the denominator is the total number of PCPs offered participation).

    18 months

Secondary Outcomes (1)

  • Percentage of items in the CDCG intervention which were adhered to

    18 months

Other Outcomes (17)

  • Standard of Care

    18 months

  • Primary Outcome Measure determination

    18 months

  • CDCG Adherence Assessment Tool

    18 months

  • +14 more other outcomes

Study Arms (2)

Communication strategy

Primary Care providers who see HIV patients and follow them on opiates for chronic pain to receive communication strategies developed by the study team wit the guidance from the HV community and providers

Other: Communication Strategy

Standard of Care

Primary Care Providers - who see HIV patients and follow them on opiates for chronic pain will receive education on the the standard information about the CDC Guidelines

Other: Standard of Care

Interventions

Communication Strategy The intervention consists of a handbook that refers to the CDC Guidelines with tools and communication strategies that the PCP can use when assessing their patients who are on opioids. The Handbook will have a description of the Ohm-app and the information the PCP can retrieve from the dashboard in their medical record. They will also be provided a template to use when seeing the patient to use as guide and as documentation.

Communication strategy

The standard information about the CDC Guidelines and no other information that is available through the study.

Standard of Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Primary Care Providers who treat HIV patients in the Institute of Advanced Medicine Institute at Mount Sinai Health System

You may qualify if:

  • Attending physician or advance practice provider in one of the Institute of Advanced Medicine (IAM) clinics
  • Designated PCP for at least 5 patients to whom he/she prescribes opioids
  • Willing and able to adhere to study procedures including randomization, and refraining from discussion of study procedures with other clinical staff or patients

You may not qualify if:

  • Unwillingness to undergo randomization
  • Plans to leave IAM within the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Icahn School of Medicine at Mount Sinai

New York, New York, 11101, United States

Location

Related Publications (1)

  • Cedillo G, George MC, Deshpande R, Benn EKT, Navis A, Nmashie A, Siddiqui A, Mueller BR, Chikamoto Y, Weiss L, Scherer M, Kamler A, Aberg JA, Vickrey BG, Bryan A, Horn B, Starkweather A, Fisher J, Robinson-Papp J. Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial. Addict Sci Clin Pract. 2022 May 16;17(1):28. doi: 10.1186/s13722-022-00311-8.

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeChronic Pain

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Jessica Robinson-Papp, MD

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 22, 2018

First Posted

September 13, 2018

Study Start

October 5, 2018

Primary Completion

September 30, 2020

Study Completion

September 30, 2020

Last Updated

October 9, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will share

Clinical information that is relevant to the provider or patient

Locations